📰 Boxed Warning News
Page 17 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
October 4, 2023
/PRNewswire/ -- The Child Neurology Society Meeting, a prominent event in the field of pediatric neurology, is set to showcase cutting-edge research and...
October 4, 2023
The FDA has approved Exxua (gepirone HCl extended-release tablets) for the treatment of major depressive disorder in adults.
October 4, 2023
WALTHAM, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant
October 4, 2023
The Child Neurology Society Meeting, a prominent event in the field of pediatric neurology, is set to showcase cutting-edge research and developments in child neurology. As part of this conference, UCB will present two late-breaking posters that shed...
October 3, 2023
(BPT) - Davitria lives with two mental illnesses and tardive dyskinesia.This article was sponsored and developed by Neurocrine Biosciences, Inc. Davitria was compensated by Neurocrine Biosciences to …
October 3, 2023
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY® (mobocertinib) in the U.S. for adult patients with epidermal growth fa...
October 3, 2023
Takeda TSE4502NYSETAK today announced that following discussions with the U.S. Food and Drug Administration FDA it will be working with the FDA towards a voluntary withdrawal of EXKIVITY mobocertinib in the U.S. for adult patients with epidermal growth factor receptor EGFR Exon20 ion mutationpositive ion locally advanced or metastatic nonsmall cell lung cancer NSCLC whose disease has progressed on or after platinumbased chemotherapy.
September 30, 2023
Epilepsy is a condition that impacts about 3.4 million people in the U.S.1 John is one of many people living with uncontrolled epilepsy who also experiences seizure clusters [3], which are marked by periods of increased seizure activity – which can be defined as two or more seizures in a 24-hour period. [2]
September 28, 2023
Data Further Position ELAHERE to Become the New Standard of Care for Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Findings to be Highlighted in Oral Presentation at ESGO Annual...